EU-wide tender
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active ingredient Calcipotriol + Betamethasone (excl. Dafo. CRE), for the period 01.07.26 - 30.06.28 (plus extension option 1x12 months).
Original title: Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Calcipotriol + Betamethason (ausschl. Dafo. CRE), für die Zeit 01.07.26 - 30.06.28 (zzgl. V.-Option 1x12 M.)
Wanted: Pharmaceutical products. The tender is called “Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active ingredient Calcipotriol + Betamethasone (excl. Dafo. CRE), for the period 01.07.26 - 30.06.28 (plus extension option 1x12 months).”. The deadline for offers is Saturday, 5 May 2029, in 916 days. Procedure: Open procedure, published EU-wide (above the EU thresholds).
- Deadline
- 5 May 2029, 916 days left, 12:00
- Published
- 15 May 2026
- Procedure
- Open procedure
- Notice
- EU-wide (TED)
- Type of contract
- Supplies
- Estimated value
- not published
- Place of performance
- not stated
- Source, last checked
- TED, 1 November 2026
Contracting authority and documents
Contracting authority only with access
Original notice (German)Tender documents on the procurement platformIn short
Discount agreement for a medicinal product containing Calcipotriol and Betamethasone for DAK-Gesundheit.
- Discount agreement for the active ingredient Calcipotriol + Betamethasone.
- Contract term from 1 July 2026 to 30 June 2028.
- Extension option for twelve months possible.
- Companies may join at any time under the same conditions.
- Offers must be submitted by email.
Summary made from the German notice and checked against it; the German original is authoritative.
Worth knowing before you bid
The contract runs for 24 months. The notice links the tender documents directly.
Dates of this tender
| Published | Friday, 15 May 2026 |
|---|---|
| Deadline | Saturday, 5 May 2029, 12:00 |
| Tender validity ends (calculated) | Monday, 4 June 2029 |
Conditions stated in the notice
| Duration | 24 months |
|---|---|
| Framework agreement | no |
| Tender validity | 1 month after the deadline |
| Suitable for SMEs | not stated |
| Security deposit | not required |
| Legal basis | GWB and VgV (German law implementing the EU directives) |
Service by CPV code
- 33600000 Pharmaceutical products
Questions and answers
When is the deadline for offers?
Until Saturday, 5 May 2029, 916 days left. The exact time and how to submit are in the original notice, which is authoritative.
Is this tender open to foreign companies?
Yes. Because it is above the EU thresholds, the procedure follows the EU directives, which rule out discrimination by nationality. Suitability can first be shown with the European Single Procurement Document (ESPD).
Which rules apply?
German procurement law implementing the EU directives (GWB and VgV; for works VOB/A EU).
In which language are the documents and the offer?
Expect German. The accepted languages are stated in the notice, and certificates in another language may have to be submitted with a translation.
Sources
Notice: TED, Amtsblatt der Europäischen Union, retrieved 1 November 2026. All information without guarantee; the original notice is authoritative.